Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 4
1990 3
1991 2
1992 5
1993 8
1994 5
1995 5
1996 3
1997 4
1998 4
1999 8
2000 8
2001 23
2002 31
2003 38
2004 40
2005 45
2006 70
2007 80
2008 86
2009 101
2010 117
2011 146
2012 181
2013 207
2014 277
2015 304
2016 312
2017 346
2018 420
2019 492
2020 586
2021 636
2022 782
2023 201
Text availability
Article attribute
Article type
Publication date

Search Results

4,990 results
Results by year
Filters applied: . Clear all
Page 1
The role of tetraspanins pan-cancer.
Huang R, Sun H, Lin R, Zhang J, Yin H, Xian S, Li M, Wang S, Li Z, Qiao Y, Jiang M, Yan P, Meng T, Huang Z. Huang R, et al. Among authors: qiao y. iScience. 2022 Jul 19;25(8):104777. doi: 10.1016/j.isci.2022.104777. eCollection 2022 Aug 19. iScience. 2022. PMID: 35992081 Free PMC article.
Small Amphiphile-Based Coacervation.
Xiao X, Jia L, Huang J, Lin Y, Qiao Y. Xiao X, et al. Among authors: qiao y. Chem Asian J. 2022 Dec 1;17(23):e202200938. doi: 10.1002/asia.202200938. Epub 2022 Oct 28. Chem Asian J. 2022. PMID: 36219462 Review.
Metal-air batteries: progress and perspective.
Chen Y, Xu J, He P, Qiao Y, Guo S, Yang H, Zhou H. Chen Y, et al. Among authors: qiao y. Sci Bull (Beijing). 2022 Dec 15;67(23):2449-2486. doi: 10.1016/j.scib.2022.11.027. Epub 2022 Nov 26. Sci Bull (Beijing). 2022. PMID: 36566068 Review.
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Among authors: qiao yl. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
4,990 results